Genotype-Guided De-Escalation of DAPT: Switching to Real-World Practice
- PMID: 39217532
- DOI: 10.1016/j.jcin.2024.07.014
Genotype-Guided De-Escalation of DAPT: Switching to Real-World Practice
Keywords: P2Y12 inhibitors; dual antiplatelet therapy; genetic testing.
Conflict of interest statement
Funding Support and Author Disclosures Dr Cavallari has received support from Werfen. Dr Franchi has received payment as an individual for consulting fees or honorarium from AstraZeneca; and has received institutional payments for grants from PLx Pharma and the Scott R. MacKenzie Foundation.
Publication types
LinkOut - more resources
Full Text Sources
